乙型肝炎病人血清聚合白蛋白受体(PHSA-r)的测定,近年来已被广泛应用。1986年我们对173例住院乙肝患者同时进行了PHSA活性及HBV-DNA的测定,现比较分析报告如下。资料和方法一、本组173例,其中男114例,女59例,按1984年南宁肝炎会议诊断标准,急性黄疸型69例,急性无黄疸型1例,急性重症2例,亚急性重症3例(以上通称急性肝炎),慢性迁延型66例,慢性活动型19例,肝炎肝硬化13例(以上通称慢性肝炎)。二、检测方法:PHSA-r测定用血凝 The measurement of serum albumin receptor (PHSA-r) in hepatitis B patients has been widely used in recent years. In 1986 we 173 cases of hospitalized patients with hepatitis B simultaneously PHSA activity and determination of HBV-DNA, are comparative analysis report is as follows. Materials and Methods First, the group of 173 cases, including 114 males and 59 females, according to the 1984 Nanning hepatitis meeting diagnosis criteria, acute jaundice 69 cases, acute jaundice 1 case, acute severe cases 2 cases, subacute severe 3 Cases (above referred to as acute hepatitis), chronic persistent type 66 cases, 19 cases of chronic active type, hepatitis cirrhosis in 13 cases (more commonly known as chronic hepatitis). Second, the test method: PHSA-r determination with blood coagulation